09:31 31 December
in
About Center
Girard Medical Center IOP/CAP is a Substance Abuse Treatment Services rehab center located in Philadelphia, PA. This drug & alcohol rehab center based in Pennsylvania provides Intensive Outpatient Treatment,Outpatient Methadone/Buprenorphine or Vivitrol,Outpatient,Regular Outpatient Treatment as treatment service option. For Girard Medical Center IOP/CAP reviews, ratings & other information, please read below.
Hospitals
- General Hospital (including VA hospital)
Language Services
- Spanish
Type of care
- Substance Abuse Treatment Services
Service Setting (e.g., Outpatient, Residential, Inpatient etc.)
- Intensive Outpatient Treatment
- Outpatient Methadone/Buprenorphine or Vivitrol
- Outpatient
- Regular Outpatient Treatment
Opioid Medications
- Naltrexone used in Treatment
Opioid Treatment
- Relapse prevention from naltrexone
- Prescribes/administer buprenorphine and/or naltrexone
Pharmacotherapies
- Extended-release
- injectible Naltrexone (Vivitrol
Facility Operation (e.g., Private, Public)
- Private Organization
Certification
- The Joint Commission
- State substance abuse agency
- State department of health
Payment /Insurance/Funding Accepted
- Medicare
- State Financed Health Insurance Plan Other Than Medicaid
Assessment
- Comprehensive substance abuse assessment
Transitional Services
- Aftercare/continuing care
- Discharge Planning
Ancilliary Services
- Mental health services
- Self-help groups
- Transportation assistance
Counselling Services
- Family counseling offered
- Group counseling offered
- Individual counseling offered
- Substance abuse education
Facility Smoking Policy
- Smoking Not Permitted
Age Groups Accepted
- Adults
- Young Adults
Gender Accepted
- Female
- Male
Screening
- Breath analyzer or blood alcohol testing
- Drug or alcohol urine screening
- HIV testing
- Screening for Hepatitis B
- Screening for mental health disorders
- Screening for substance abuse
- STD testing
- TB screening
Directions to Center
Related Rehab Centers
Sorry, the comment form is closed at this time.